Intec Pharma (NTEC) News Today → Now Open: Crypto emergency update (From InvestorPlace) (Ad) Free NTEC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial Outlookmarkets.businessinsider.com - March 15 at 8:35 AMBuy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 with Promising Developmentsmarkets.businessinsider.com - March 7 at 12:54 AMStocks to Watch Today: RVNL,Glenmark Pharma, PB Fintech,Sula Vineyards and moremsn.com - February 18 at 11:25 PMChhattisgarh education minister calls for expansion of central schools in the statemsn.com - February 2 at 7:53 AMH.C. Wainwright Sticks to Its Buy Rating for Indaptus Therapeutics (INDP)markets.businessinsider.com - August 15 at 9:46 AMNGENF - NervGen Pharma Corp.finance.yahoo.com - June 16 at 12:03 AM10-Q: INDAPTUS THERAPEUTICS, INC.marketwatch.com - May 12 at 12:11 AMFibromyalgia Treatment Market Research | 2023-2030marketwatch.com - May 10 at 2:05 AMEarly Pregnancy Test Kit Market May Set Epic Growth Story Major Players – Abbott, Church & Dwight, SPD Swiss Precision Diagnostics GmbHmarketwatch.com - May 9 at 8:55 PMFibromyalgia Treatment Market Share, Size, Financial Summaries Analysis from 2023 to 2028marketwatch.com - May 4 at 7:25 PMFibromyalgia Treatment Market Share by 2031marketwatch.com - April 28 at 12:35 AMIntec Pharma Ltd (5NU.SG)ca.finance.yahoo.com - April 24 at 5:27 PMFibromyalgia Treatment Market Size, Share, Outlook and Forecast to 2031marketwatch.com - March 30 at 9:54 AMMaxim Group Reaffirms Their Buy Rating on Indaptus Therapeutics (INDP)markets.businessinsider.com - March 18 at 10:19 AMFibromyalgia Treatment Market Forecast: An Analysis of Industry Trends for 2023-2028marketwatch.com - March 2 at 7:54 AMGlobal Parkinson’s Disease Treatment Market Opportunities, Business Statistics Research Report 2030 By VMReportsmarketwatch.com - February 19 at 8:31 AMFibromyalgia Treatment Market Size 2023 With Over-All Dominated, Share Of Everywhere, Ease Of Access Of Solutionsmarketwatch.com - February 15 at 7:01 PMSyphilis Rapid Test Kit Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028marketwatch.com - January 30 at 10:56 AMFibromyalgia Treatment Market Industry Updates, New Opportunities, Major Strategies, And Forecast 2028marketwatch.com - January 23 at 11:14 PMWith 1.7% CAGR, Fibromyalgia Treatment Market 2023 Is Flourishing Around the World by 2028 | 116 Pages Reportmarketwatch.com - December 29 at 8:36 AMFibromyalgia Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2028 | 116 Pages Reportmarketwatch.com - December 21 at 7:50 AMFibromyalgia Treatment Market Size in 2022 with Latest Report of 100 Pages & Business Forecast up to 2028 by Value Chain Analysis | No of Pages 100marketwatch.com - October 17 at 5:33 PMFibromyalgia Treatment Market Size and Share 2022 Analysis Report by Industry Trends, Drivers, Applications, Sale and Forecast to 2028marketwatch.com - August 28 at 8:15 PMWorld Holdings Co Ltd (2429)investing.com - July 5 at 10:01 AMBeroe Inc.: Beroe partners with Mintec to power its intelligence offering with market-leading commodity price datafinanznachrichten.de - June 4 at 4:01 AMEXEL INDUSTRIES :2020-2021 Full-year results: Significant improvement in margins combined with a sharp reduction in debtfinanznachrichten.de - December 18 at 8:25 PMDataiku Increases Commitment to the Japanese Market to Accelerate Everyday AI in Japanyahoo.com - December 10 at 8:02 PMGenetron earnings preview: what Wall Street is expectingmarkets.businessinsider.com - December 1 at 11:16 PMHere's what Wall Street expects from Cipher Pharmaceuticals's earningsmarkets.businessinsider.com - November 12 at 7:06 AMIntec Closes Merger with Decoy Biosystemsfinance.yahoo.com - August 3 at 8:54 PMIntec Announces Expected Closing Date of Decoy Mergerfinance.yahoo.com - August 3 at 3:53 PMIntec Parent Shares Up 60%marketwatch.com - July 29 at 6:26 PMmarketbeat.com - July 29 at 11:09 AMmarketbeat.com - July 29 at 10:25 AMBRIEF-Intec Announces $30 Mln Private Placement Ahead Of Decoy Mergermsn.com - July 26 at 3:09 PMIntec Pharma in $30 Million Private Placementmarketwatch.com - July 26 at 10:08 AMIntec Announces $30 Million Private Placement Ahead of Decoy Mergerfinance.yahoo.com - July 26 at 10:08 AMIntec Pharma Ltd. Ordinary Shares (NTEC)nasdaq.com - July 25 at 12:38 AM Get Intec Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NTEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. NTEC Media Mentions By Week NTEC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTEC News Sentiment▼0.000.53▲Average Medical News Sentiment NTEC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTEC Articles This Week▼00▲NTEC Articles Average Week Get Intec Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NTEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KTTA News CMMB News EFTR News BNOX News VCNX News GRTX News CLVR News ATHE News VIRI News PCSA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTEC) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intec Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.